A Hitherto Undescribed Congenital Haemorrhagic Diathesis Probably Due to Fibrin Stabilizing Factor Deficiency

Summary

A new congenital haemorrhagic diathesis is described. It is characterized by the poor and slaw wound healing, profuse and long bleeding and by probable absence of spontaneous and joint bleeding. It is due to the deficiency of a factor which makes the fibrin clots insoluble in urea. This factor is probably the fibrin stabilizing factor of Laki and Lorand, although no proof of their identity can yet be given. The deficiency appears in both sexes and is probably an autosomal recessive disease.

• Reference

• 1 Laki K, Lorand L. On the Solubility of Fibrin Clots. Science 108: 280 1948;
• 2 Loewy A. G, Edsall J. T. Studies on the Formation of Urea-Insoluble Fibrin. J. biol. Chem 211: 829 1954;
• 3 Loewy A. G, Venziale C, Forman M. Purification of the Factor Involved in the Formation of Urea-Insoluble Fibrin. Biochim. biophys. Acta 26: 670 1957;
• 4 Lorand L, Jacobsen A. Studies on the Polymerization of Fibrin. The Role of the Globulin: Fibrin Stabilizing Factor. J. biol. Chem 230: 421 1958;
• 5 Lüscher E. F. Ein fibrinstabilisierender Faktor aus Thrombozyten. Schweiz, med Wschr 87: 1220 1957;
• 6 Nilsson I. M, Blombäck M, Jorpes E, Blombäck B, Johansson S. A. v. Willebrand’s Disease and its Correction with Fluman Plasma Fraction 1—0. Acta med. Scandinav 159: 179 1957;
• 7 Nilsson I. M, Sjoerdsma A, Waldenstrom J. Antifibrinolytic Activity and Metabolism of 8-aminocaproic Acid in Man. Lancet 1960; 1332.